Synergistic Activity of Paclitaxel, Sorafenib, and Radiation Therapy in advanced Renal Cell Carcinoma and Breast Cancer()()

Advanced cancer has been shown to be associated with a higher percentage of epigenetic changes than with genetic mutations. Preclinical models have shown that the combination of paclitaxel, sorafenib, and radiation therapy (RT) plays a crucial role in renal cell carcinoma (RCC) and breast cancer. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Kyung Hwa, Jeon, Jeong Yong, Lee, Young-Eun, Kim, Seung Won, Kim, Sang Yong, Yun, Yeo Jin, Park, Ki Cheong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279801/
https://www.ncbi.nlm.nih.gov/pubmed/30522045
http://dx.doi.org/10.1016/j.tranon.2018.11.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279801/
https://www.ncbi.nlm.nih.gov/pubmed/30522045
http://dx.doi.org/10.1016/j.tranon.2018.11.007

Ejemplares similares